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Abstract  
Purpose:  “She wouldn’t remember. Even when I go through, and she’s decided to go to bed, I’ll 
say I’ll come and do her drops. If I didn’t say that, they wouldn’t be done.” Dementia is widely 
considered a key factor in whether patients take their medication as prescribed. However, few 
studies have examined the effect of dementia upon medication management strategies for 
glaucoma including how patient and carer needs impact adherence and long term prognosis. We 
report findings from a qualitative grounded theory study incorporating the views of patients, carers 
and healthcare professionals. 
Patients and methods: 83 semi-structured interviews were conducted with 35 patients, 22 lay 
carers and nine healthcare professionals across sites in Wales and Scotland. These explored 
understanding of eye drop regimens, barriers and facilitators to drop administration, as well as 
attitudes towards glaucoma, dementia and other comorbidities. 
Results: Using Pandora Pound’s synthesis of adherence behaviour, we identified categories of 
active and passive acceptance of medicines, alongside modification or rejection of eye drop 
regimens. In relation to dementia, participants highlighted transitions between such categories, 
with a shift from active to passive acceptance commonly reported. This loss of self-medicating 
capability was referred to as the precipice of care, where entwinement of multiple conditions (eg 
heart disease, glaucoma and dementia) and socio-cultural influences (eg living alone) contributed 
to accelerated health declines. That said, numerous factors mitigated this, with a key role being 
the lay carer. Spouses and family members often acted as the monitor of eye drops for patients, 
seeking intervention when any behavioural changes influenced their administration. 
Conclusion: Though dementia was associated with progression towards the precipice of care, 
factors such as communication with healthcare professionals appeared to affect patient 
adherence. Recommendations for healthcare practice include better recording of dementia 
diagnoses and integrating eye drops into pre-existing routines. 
 
Keywords: memory loss ; compliance ; eye drops ; qualitative research ; grounded theory 
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Introduction 
The World Health Organisation (WHO) 2003 report on adherence to long-term therapies 
emphasised concerns over patients failing to take medications as prescribed. 1 It stated that the 
estimated worldwide adherence rate for chronic conditions was around 50 percent, with this 
reducing clinical benefits and wasting medical resources. 1 Research into non-adherence is 
ongoing, with numerous contributory variables identified, such as physical difficulties, 
psychosocial issues, side effects, beliefs about medication, organisational healthcare issues and 
condition-specific factors. 2 Adherence is, therefore, a complex issue and for each disease or 
person, varying factors have differing impacts. 3 
 
Age-related conditions fit into the priorities set by the WHO, tending to be chronic and long-term. 1 
Worldwide, the population aged 60 or over is projected to rise by 56 percent from 901 million in 
2015 to 1.4 billion in 2030. 4 This trend is coupled with a rise in those over 85, with the UK 
expecting this figure to double to 3.2 million by 2034. 5 With this population growth comes the 
likelihood of increases in age-related conditions, prompting concerns of over-stretched healthcare 
systems where prolonged self-medication is increasingly important. 6 Though Banning noted poor 
adherence irrespective of age, for older people this can be particularly unpredictable with them 
often encountering complex regimens across multiple conditions, as well as adverse drug effects. 
7
 It is estimated that, while 45 percent of medicines prescribed in the UK are for older people, up 
to 50 percent of that population are non-adherent. 8 Numerous studies have researched 
adherence behaviour, with recent emphasis on the use of qualitative techniques to determine lay 
attitudes towards medication and the underlying causes for non-adherence. 9 Many of these 
studies have helped to progress the field, offering functional models of active or passive 
adherence, resistance and modification. 10 However, few qualitative studies have examined this 
issue in relation to older people, with fewer still including people with dementia and how this 
pertains to the administration of medication. Arlt et al’s literature review aggregated much of the 
 4 
research on dementia and adherence, outlining the need to more fully examine patient, carer and 
healthcare professional management strategies. 11 
 
This article reports on qualitative, grounded theory research examining the effect of dementia 
upon medication management for the degenerative eye condition glaucoma. Internationally, 
glaucoma is one of the largest causes of permanent, severe visual impairment with an estimated 
75 million people affected. 12 In the UK context, glaucoma affects around 600,000 of those aged 
over 65, although it is suggested that a further half of all cases may remain undiagnosed. 12 The 
most common form of treatment for the condition is the instillation of daily eye drops that reduce 
the build-up of intraocular pressure responsible for damaging the optic nerve. 13 Lifelong 
adherence to eye drops is a key concern for healthcare practitioners given that the damage 
caused by glaucoma is irreversible. Much like glaucoma, dementia is also a degenerative 
condition and affects around 47 million people worldwide, with this expected to be nearer 75 
million by 2030. 14 For the UK, dementia affects approximately 815,000 people aged over 65 in 
the UK, with this also expected to increase over time. 15 The age-related nature of both conditions 
implies considerable overlap in the affected populations, with numerous authors highlighting the 
negative impact that dementia may have upon adherence (e.g. Jain and Ahmad, 2015). 16 No 
previous studies have explicitly examined this issue using qualitative methods that would identify 
common underlying behaviours and decision-making for patients, carers and healthcare 
professionals. The findings have the potential to impact on national and international health care 
policy, particularly through the National Institute for Health and Care Excellence (NICE) 
guidelines on glaucoma diagnosis and management (NICE, 2017). 17 
Material and methods 
The research study adopted a grounded theory approach based on the requirement to study 
people’s experiences and identify an underlying process; 18 in this case, the management of eye 
drops for those affected by both a form of dementia and glaucoma. Key features of grounded 
theory are i) the simultaneous collection and analysis of data so that one informs the other ii) 
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targeted sampling to expand or verify the emerging theory and iii) the constant comparison of 
new data with previously collected data to ensure the relevance of all to the theory. 19 
 
Data Collection and Sample 
Participants were recruited from glaucoma clinics in two countries, Wales and Scotland, between 
May 2016 and April 2017. Inclusion criteria for patients with dementia and glaucoma (patient 
cohort A) were: aged 18 or over, diagnosed with a form of glaucoma and dementia, able to 
provide informed consent according to the Mental Capacity Act 2005, and prescribed ocular 
hypotensive therapy. Patient records for those attending the glaucoma clinics were examined to 
confirm the diagnosis of dementia and identify potential participants in advance of appointments. 
A member of the clinical team informed attendees of the study and, if interested, introduced them 
to the research team for further information. Carers were eligible if aged 18 or over and were 
providing lay care to someone with both glaucoma and dementia. In general, carers were 
recruited when attending the glaucoma clinic with the patient. The healthcare professionals were 
required to be aged 18 or over and providing clinical care for those diagnosed with dementia 
and/or glaucoma.  
 
We obtained an initial sample of 23 patients with a form of dementia and glaucoma (cohort A), 22 
lay carers and nine healthcare professionals. As the project progressed, an analytical theme on 
the relative importance of multiple conditions led to the study expanding to incorporate two 
additional patient cohorts. These comprised six patients experiencing just glaucoma (cohort B) 
and six patients who had glaucoma with another non-dementia comorbidity (cohort C). From our 
total of 66 participants, 17 with dementia and glaucoma were interviewed twice in six months. 
Overall, this generated 83 semi-structured interviews lasting between 30 and 60 minutes. The 
interview schedule explored the experiences of people with glaucoma and dementia, 
management and understanding of eye drop regimens, and any side effects, barriers and 
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facilitators to drop administration. These topics were deliberately kept flexible to allow the 
inclusion of unexpected themes in later interviews. 
Data Analysis 
Thematic data analysis was carried out in line with the principles of grounded theory in which 
themes emerge as data was collected (Glaser, 1996). 20 NVivo 10 was used to organise and 
aggregate data within the developing framework. Analysis commenced by indexing the data and 
exploring topics considered important to broad medication adherence, before focusing specifically 
on glaucoma eye drops. The meaning of sentences or paragraphs was coded, to construct a list 
of relevant categories. Each of these underwent constant comparative data analysis before being 
grouped into interrelated themes and concepts. During the analysis, memos were written 
between researchers to record developing ideas resulting in the expansion of the study to include 
the two further patient cohorts mentioned above. 19 These interview transcripts were included in 
the wider data and were subject to the same analytical approach. Theoretical sensitivity to other 
literature was also important in providing insight into the emerging themes, with Pound et al’s 
synthesis of qualitative studies offering an analytical filter to help understand the emergent data. 
10
 Eventually, an overarching theory was generated relating all the concepts together, with key 
components including the influence of pre-existing routines, attitudes towards medication and the 
importance of carers in slowing deterioration. 
Ethics 
The study was granted ethical approval by the Wales 2 NHS Research Ethics Committee (Ref: 
16/WA/0006) and approved by NHS R&D prior to the commencement of data collection. Written, 
informed consent was obtained from all participants prior to the interviews taking place, with 
particular care taken for people with dementia. In these cases, capacity to consent was assessed 
according to the British Medical Association’s (BMA) Mental Capacity Act Toolkit. This 
assessment included ensuring that participants understood and retained information relevant to 
the decision, used this to decide on participation and were able to communicate their response. 21 
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In addition, researchers used a form of ‘process consent’ in which verbal agreement was sought 
throughout the interview schedule. 22 Both the initial capacity assessment and ongoing process 
consent were also carried out during the second round of patient interviews. All quotations taken 
from the interview data were anonymised to prevent participant identification.  
Dataset 
Tables 1 to 3 summarise the study participants from both research sites in Scotland and Wales. 
All of the patient participants were aged over 70 with just over half being female. Two thirds of 
patients with dementia (cohort A) had been diagnosed with either mild or moderate Alzheimer’s 
disease, with the remainder suffering from either vascular or mixed dementias. Similarly, two 
thirds of the patients suffered from primary open angle glaucoma with the other third having 
normal tension glaucoma. This includes non-dementia patient cohorts B (glaucoma only) and C 
(glaucoma and another comorbidity other than dementia) where comorbidities included aortic 
stenosis, diabetes, diverticulitis and chronic back pain. The lay carer participants were generally 
family members with varying degrees of experience in caring for their proxies. Their ages ranged 
between 50 and 90 years old with the majority caring for one of the cohort A patients. Over three 
quarters of those in the lay caring role were female. The healthcare professionals comprised key 
members of the glaucoma clinic with roles including consultant, optometrist, nurse, and eye clinic 
liaison officer (ECLO). 
Results 
Pound et al’s synthesis of qualitative studies on medication adherence underpins the 
development of a model of behaviour incorporating active or passive acceptance, rejection and 
modification of prescriptions. 10 These categories highlight the complexity of adherence 
management, with greater centrality given to lay understandings and attitudes. In line with the 
theoretical sensitivity associated with the grounded theory approach, Pound’s model was useful 
in corroborating the study’s emergent themes. Alignment was found between both studies 
through themes such as belief in the value of medication, minimising intake, communication with 
 8 
healthcare professionals and the influence of a carer on adherence. Thwaites has conceived of 
medication management as a continuum commencing from the initial prescription until the 
completion of the course. 23 In chronic, degenerative conditions such as glaucoma and dementia, 
the course of medication is often lifelong, meaning this continuum exists from diagnosis onwards. 
However, as Insel et al note, those experiencing dementia and decline in executive function may 
develop problems in formulating a plan to take their medicines, using assistive strategies and 
recalling that they took the medication. 24 Our findings support this view, although a key focus 
was on transitions between states of adherence, how dementia affected this, and what mitigated 
or accelerated the transition. 
Categories of Adherence 
Pound et al identified two primary categories of those who adhered to their medicine as 
prescribed; either passive or active accepters. 10 Interviews with each of our participant cohorts 
saw individuals falling into these categories, although there was also evidence of fluctuation 
between them. 
Active Accepters 
Active accepters of medication have been described as ‘purposeful’ adherers; a prerequisite of 
which is the perception that a prescription is necessary, effective, and safe. 25 These factors 
promote a willingness to follow regimens, often also based on pre-existing understandings of 
conditions and their consequences. In relation to glaucoma patients, similar ideas were evident: 
Your eyesight is very precious. I would rather go deaf than lose my eyesight. 
So, oh no, I put the drops in. WP15, Patient 
 
I’ve put dates on them, because they need to be used by a certain date… 
your sight is precious, isn’t it? So I do what I’m told. WPB02, Patient 
 9 
These extracts show respondents’ acceptance of glaucoma medication. The quote from WP15 is 
indicative of how acceptance can be maintained through the early stages of memory loss. 
However, this theme was often more evident in the accounts of carers. One saw their mother 
maintain fastidious adherence to medication over a period of several years before eventually 
declining: 
She would really do it to the letter…she used to say I have to take them the 
last thing of the day…the consultant had told her that she should put them in 
and she should hold her fingers in her eyes for 60 seconds, and then once 
that was done, that was successful. WC06, Carer 
This patient’s dedication to adherence saw her follow the consultant’s instructions ‘to the letter’. 
While the carer attributed this approach to the patient’s attitudes towards their eyesight, she 
suggested her deference to the healthcare professional also contributed. Indeed, another patient 
participant categorised as an ‘active accepter’ offered a similar account when considering their 
own adherence: 
I: Is it the fear of what would happen if you didn’t take your medicine?  
R: No, it’s just the fact that they say, “Take this”. WP11, Patient 
Also recurrent within the accounts of active accepters was the importance of pre-established 
routines, aligning with Insel et al and While et al. 24, 26 The extract below is from a carer outlining 
their mother-in-law’s capability to instil eye drops after five years with mild Alzheimer’s: 
It’s been a long term thing, it seems to be the one that’s staying stable…I 
think it’s because in herself she’s always had a routine, always kept a 
calendar. WC10, Carer 
The carer felt that her mother-in-law’s active acceptance and self-administration of the glaucoma 
drops was developed by the longevity of her routine, pre-established prior to the diagnosis of 
Alzheimer’s. Further accounts of beneficial routines were evident where eye drops were 
integrated into wider medication regimens: 
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We’re in a nice wee routine just now and I think it’s fine that we keep that 
routine and we’ve gone over it again and again. SC01, Carer 
 
So when I go to bed they're there on the landing. The last thing I see before I 
go into the bedroom is these rows of pills. WP11, Patient 
Routines were often entwined with visual stimuli such as the strategic placement of eye drops or 
a visible record to aid memory, particularly for patients living alone. Carers also adopted these 
strategies upon realising that memory loss may be affecting adherence. The placement of signs 
and calendars in familiar locations was reported by several carers, as well as the non-intrusive 
monitoring of medicine taking: 
He does it himself. I’ve got to tell him, before we go to bed I say don’t forget 
eye drops, in the fridge. WC04, Carer 
 
When we come over, and that’s once a week from Bristol, I leave mum a little 
note on her bedside table to remind her to put the drops in that evening. 
WC14, Carer 
Referring back to Thwaites’ notion of a continuum, accounts of carers and patients outlined 
several phases of decline from active acceptance triggered by dementia. 25 In both cases above, 
the carers expressed concern that reminders might lose their effectiveness or provoke greater 
dependence. WC14 went onto state that she found reminder notes discarded in a drawer, 
prompting concerns over forgetfulness. While these patients were actively self-administering, 
there was growing reliance on the carer to monitor and maintain independence. 
Passive Accepters 
Pound et al’s model suggested ‘passive accepters’ were either those who adhered indifferently 
towards their medication, or those who relinquished control to others. 10 The majority of passive 
accounts in this study fell into the latter category, with carers often recognising patients’ 
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medication management required intervention. This issue was particularly clear in a carer’s 
account of her mother’s declining fastidiousness: 
She was very much in control of it until…in the last two years…her 
understanding of things became less, and then to remember to do things and 
what is this and why have you done that. WC06, Carer 
This carer’s mother had recently moved to a care home and was now entirely dependent on staff 
to instil her drops. The transition to sheltered housing or care home environments was evident in 
several cases and tended to coincide with medication not being remembered. The case below 
provided a snapshot of this as an emergent situation, with the carer beginning to realise her 
mother’s drops were being missed: 
We have, with mum’s permission, started to look at care homes…not actually 
here in Wales but in England where we live. Because I am the only child, and 
we felt…it would be better for it to be near us. WC14, Carer, cited in 
interview ref: WP14 
A perceived change in cognition appeared to dictate the move to a care home with many elderly 
patients previously self-managing their medication. However, an awareness of deterioration 
tended to press the carer into investigating sheltered housing. For many, this decision was 
considerably stressful and often compromised long-established independence. Some preferred 
the patient to remain at home, instead arranging for care visits. There were, however, significant 
variations in the level of assistance provided by care staff; some patients were brought their eye 
drops to self-administer, while others required direct administration. Though generally determined 
by patient capability, the care home or visiting staff also influenced the mode of administration: 
I’m hoping that maybe the carers can…they’re not allowed to administer the 
eye drops but I’m hoping I can try and get through to them that even if they 
could stand over her while she takes them...WC01, Carer 
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In this case, visiting carers were unqualified to administer eye drops and could not mitigate the 
risk of non-adherence. Though verbal reminders were generally provided, these were not 
considered effective. However, in other cases, the transition to passive adherence was smoother 
as drops were brought to the patient and instilled independently. Moving to a care home or 
integration of visiting carers was more common in the absence of a live-in carer, such as a 
spouse or family member. Son or daughter carers were sometimes unable to visit the patient 
every day which, when coupled with doubts about adherence capability, led to more complex 
arrangements. However, in cases where elderly patients lived with their spouse, the management 
of medications could become part of their caring role: 
She wouldn’t remember. Even when I go through, and she’s decided to go to 
bed, I’ll say I’ll come and do her drops. If I didn’t say that, they wouldn’t be 
done. WC03, Carer 
This extract suggests that memory loss prevented the carer’s wife from taking her drops. In 
addition, her transition into passive adherence was related to her inability to self-administer the 
drops accurately, often missing her eye. Indeed, the shift to passive adherence often appeared to 
be less related to forgetfulness and more to pre-existing dependence between patient and carer: 
I’ve got no idea of whether I’d get my eye. I just hold them back and she drops 
them in. WP06, Patient 
 
The way I manage is my wife says come here, you’ve got to put your head 
back and she puts the drops in. WP07, Patient 
These extracts were taken from passively adherent patients reliant on their spouses for eye drop 
administration. While other accounts demonstrated cognitive and physical decline were heavily 
influential, these were not the primary trigger in these cases. Instead, it was reported that patients 
were dependent upon their spouses for direct administration from diagnosis onwards, even 
though physically capable. This suggested that dependence upon a carer may be influenced by 
pre-existing attitudes towards medicine-taking and dynamics in the patient-carer relationship. 
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Categories of Non-Adherence 
Both categories of medication acceptance reported eye drops being instilled successfully. Non-
adherence was also reported in some cases, particularly in the transition between activity and 
passivity. The National Institute for Health and Care Excellence 2009 guidelines on adherence 
categorise this as unintentional non-adherence, driven by forgetfulness. 27 Within the same 
guidelines, intentional non-adherence is characterised by the ‘beliefs and preferences that 
influence the person's perceptions of the treatment’. 27 Pound et al provided insight into these lay 
beliefs, focussing on the rejection and modification of regimens. 10 The former category is 
characterised by scepticism over the medication, leading to conscious and purposeful non-
adherence; the latter is comprised of those who actively adapt their intake. 10 
Rejection 
Accounts of rejection of medication were relatively uncommon for those with dementia. The 
majority of participants expressed acceptance of their eye drops, with this being compromised by 
memory loss. Nevertheless, thematic analysis revealed several attitudinal factors influencing the 
adoption of strategies to manage eye drops. Taking the condition of glaucoma seriously was a 
key prerequisite to active acceptance, yet some participants appeared to deprioritise it: 
R: She does it when she thinks about it. When you remember you do it, don’t 
you? 
R2: I’m a bit naughty… 
R: Because it isn’t giving her any trouble, she isn’t bothered with it, you know? 
WC02, Carer (R) and WP01, Patient (R2) 
This elderly couple self-reported inconsistent adherence to eye drops, corroborated by their 
daughter referencing ‘two carrier bags’ full of unused medication (WC01, Carer). While 
forgetfulness was mentioned, it was also apparent that glaucoma was not provoking any 
noticeable visual problems for the patient, prompting a more ambivalent response to treatment. 
Previous studies have highlighted the asymptomatic nature of glaucoma contributing to non-
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adherence, with long-term impacts initially unclear. 28 This was further heightened by the 
presence of other comorbidities including dementia and arthritis, each of which appeared to be 
considered more important than glaucoma: 
Well, in fact, I don’t give her eyes a thought actually because they aren’t that 
important. No, it’s more like other things take priority over them at the 
moment. WC02, Carer 
Glaucoma’s de-prioritisation relative to other conditions was apparent across all patient cohorts, 
both with and without dementia. For those with symptoms of memory loss, these were often 
regarded as the primary concern. That said, for the majority of this cohort, carers helped to re-
establish eye drops as important by encouraging and reminding their proxy. The extract above 
suggests that if carer and patient both deprioritise the condition, there is a greater likelihood of 
non-adherence. In contrast, another patient with dementia believed he could remember eye drops 
but remained apathetic: 
I: Would you have problems remembering to take your eye drops if your wife 
wasn’t here to help you? 
R: Not really. I probably wouldn’t bother. WP21, Patient 
The patient reiterated his ambivalence was responsible for historic non-adherence to eye drops 
throughout the interview. Here, the patient lived with his wife who now instilled the drops, 
commencing a period of passive acceptance. Nevertheless, the patient’s attitude to glaucoma 
was in stark contrast to his other conditions. Indeed, many of those with a condition other than 
dementia also noted their prioritisation of these over glaucoma: 
You can pop off quickly with the heart and you don’t pop off quickly with 
glaucoma. WPC01, Patient 
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I know part of my colon is affected and I'm going to have part of that 
removed…but that affects me, the glaucoma and the cataracts don’t really 
affect me. WPC04, Patient 
 
I: Which of the conditions would you say concerns you the most? 
R: I suppose the cardiac problem…I don’t think of my eyes at all. WPC06, 
Patient 
For some participants, glaucoma appeared to be considered less serious than other conditions, 
potentially influencing attitudes towards eye drops. Nevertheless, the majority of participants did 
not reject the medication outright. The only instance in which eye drops were abandoned 
altogether came from a patient with chronic back pain: 
One stage playing golf my eyes watered excessively…for some reason I 
stopped the prescribed drops…I got told off about that because apparently my 
eye pressure went up. WPC05, Patient 
Interestingly, unlike many accounts of acceptance where carers and patients saw association 
between glaucoma and blindness, this patient rejected the medication without understanding the 
consequences. This implies inadequate patient education at diagnosis which, when experiencing 
side effects, triggered a period of non-adherence. The interviewee went onto outline that positive 
interactions with healthcare professionals altered this behaviour, highlighting the influence of 
clear, person-centred communication within the clinic. 
Modification 
Pound et al’s category of modifiers suggested active engagement from patients, with medicine 
being taken but not necessarily as prescribed. The motivations for patients to modify their 
regimen may be pre-existing suspicion towards it, side effects, or minimising the impact it has on 
their lives. 10 Accounts of modification behaviour were less pervasive within the interviews than 
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those of active or passive acceptance. Nevertheless, some patients sought to shift their 
medication patterns: 
The lady that I saw when I saw you before, I said that if I go out for a pint I’ll 
put them in before I go. She said that’s a good idea as when you come back 
you can forget it. WPC06, Patient 
This patient modified his prescription on evenings where he went out socialising. This was agreed 
with a member of the glaucoma clinic suggesting that co-operation between patient and 
healthcare professional could optimise medication intake. Many healthcare professionals stated 
that they would rather have patients modify their routines if it encouraged eye drop use: 
I’ve got some patients who just can’t remember to do things in the 
morning…or vice versa…if you were just to say well do it all together rather 
than being fixed…I think that would make life a lot easier. WH02, Optometrist 
This person-centred flexibility to regimens demonstrates how healthcare professionals, carers 
and patients can collaborate to identify the most appropriate, personalised routines. 27 In terms of 
patients with dementia, flexibility could also facilitate better intake of eye drops. The value of 
routines for both active and passive accepters of the medication has already been outlined and, 
as the following example shows, disruption or deviation can result in poorer levels of adherence: 
When he was putting them in at night time, he was used to it. But now 
because of the change in the time, he’s more forgetful. WC12, Carer 
This carer reported that a healthcare professional suggested moving her husband’s eye drops 
from the evening to the morning. This was intended to maximise the effectiveness of the drops, 
but ultimately resulted in less adherence and an additional burden on the carer to monitor intake. 
The participants believed that the healthcare professional was unaware of the husband’s 
diagnosis of dementia yet passively accepted their instructions. Knowledge of the patient’s 
comorbidities may have prevented advice that could compromise rather than benefit medication 
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adherence. Open, person-centred discussion between carers, patients and healthcare staff may 
help to ensure that all parties agree the best management strategy. 
Discussion: Adherence Transitions and the Precipice of 
Care 
Thwaites’ continuum of care presents adherence as a linear path from prescription to completion 
of the course. 23 While Pound et al’s categories of adherence and non-adherence offer a 
functioning snapshot of a patient’s status, the factors influencing transitions between them are 
less transparent. 10 This discussion centres on how dementia affects these transitions, while also 
examining factors relevant to those with and without memory loss. The most common shift in 
reported adherence behaviour was from a state of active to passive acceptance. Carers who had 
witnessed a decline in the patient’s ability to self-manage medication described the progression 
as being from independence to partial and then complete dependence. Even so, numerous 
carers referenced long spells of fastidious adherence that ran counter to the predicted pathway, 
with the patient sustaining self-management many years post-diagnosis. Variables such as type 
and severity of dementia naturally contribute to the experienced decline, but the points outlined 
below were reported as having potential to slow progress towards a precipice of care. 
Belief in Value of Medication and Healthcare System 
Belief in the value of medication and the wider healthcare system is associated with active 
management of medication. 10, 25 The majority of participants regarded medication as important 
and, in relation to glaucoma care, this belief was generally predicated on understanding the 
condition. Many adherent patients expressed anxiety over the potential for glaucoma to develop 
into blindness, and how this explained their fastidious use of eye drops. This aligns with findings 
from various eye drop adherence studies where those who saw the necessity of taking drops 
were more adherent. 29, 30 The counterpoint to this was believing eye drops were unnecessary, 
commonly linked to a lack of patient awareness of the condition. 31 Only one participant 
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expressed this view, reporting a spell of non-adherence after encountering watery eyes. In this 
case, treatment was resumed following an appointment in the glaucoma clinic where healthcare 
professionals reasserted the medication’s importance. Interestingly, this patient did not have 
dementia, suggesting that educational interventions may be useful for all patients receiving a 
glaucoma diagnosis. For people with dementia and glaucoma, a belief in the value of eye drops 
did not necessarily prevent the transition from active to passive acceptance or non-adherence. 
Nevertheless, continued eye drop use was dependent on the perception of glaucoma as a 
serious condition. 
Relative Importance of Conditions and Comorbidities 
Older people often experience multiple comorbidities which can be problematic both for 
medication adherence and the care burden. 32, 33 Many participants had conditions other than 
glaucoma and dementia, with arthritis and cardiac issues being particularly common. For some of 
these participants adherence to glaucoma drops was deprioritised relative to other conditions. 
Numerous authors have indicated how adherence to medication can be guided by symptomatic 
experience. 25, 34 Glaucoma care does not fit neatly within this on the basis that is generally 
asymptomatic and characterised by gradual visual decline. 28 This model of symptomatic 
progression appeared to impact upon the importance attributed to eye drops compared with other 
medications, more so if the care burden was particularly heavy. A greater understanding and 
awareness of glaucoma was associated with a belief in the value of medication to prevent its 
progression on the part of patients and carers. Healthcare professionals looking to improve 
adherence should be looking to identify this set of patients, be aware of their healthcare 
requirements and attempt to integrate the drops into their broader, pre-existing medication suites. 
Pre-Established Routines 
The perceived value of routines in dementia care has been widely documented in the healthcare 
community. 35, 36 Supporting data has documented participant engagement with long-established 
routines after a dementia diagnosis. Many of those diagnosed with glaucoma before dementia 
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maintained their eye drop regimen, apparently due to it being embedded in their daily activities. 
Carers often stated that patients’ pre-diagnosis life had involved the daily use of diaries and 
calendars which they felt prolonged the phase of active acceptance. The importance of this also 
emerged when patients sought to modify their regimen. For people with dementia, this often 
involved integrating drop administration with other established routines. The use of time-based 
blister packs helped many with dementia orientate themselves to their pills, often alongside other 
memory aids. Eye drops, however, do not fit within such packs leaving them at risk of being 
overlooked. Future studies should consider integrating visual aids such as stickers onto blister 
packs, representing the requirement to take eye drops for those with memory-driven adherence 
issues. This approach would be dependent on healthcare professionals offering person-centred 
flexibility and recognising that general prescription advice may not be applicable for all patients. 
Presence of Carer 
Lay carers of people with dementia are widely acknowledged for their role in medication 
management. 37, 38 The study data reflected this with numerous instances where spouses or other 
family members assumed control of medication management once passive acceptance was 
reached. However, the carers were also shown to assist with independent self-management 
through monitoring and reminders. Carers were also helpful in identifying subtle shifts in 
behaviour that may affect the transition between adherence categories. This tacit knowledge 
extended to the patient’s preferences and routines, helping to inform modifications beneficial to 
intake. Even so, the role of carer is associated with a considerable burden that often goes 
unacknowledged by healthcare professionals. 39 Given the importance of carers in identifying and 
preventing transitions between states of adherence, providing adequate support is essential. 
Several carer participants engaged with organisations such as Alzheimer’s Society, Age UK or 
similar services suggested by their GP. Activities included counselling, communication strategies 
and access to a network of others with dementia. These were widely reported as helpful, 
suggesting that healthcare professionals could provide further information on such services if 
aware of a dementia diagnosis. The importance of the carer in disclosing the diagnosis of 
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dementia was raised by numerous healthcare professionals. Glaucoma clinics are extremely busy 
with little time to study patient records and identify dementia diagnoses, should they even be 
routinely recorded. The identification and awareness of dementia is among the first steps in 
healthcare professionals providing appropriate strategies for medication and other aspects of 
daily life. 11, 26 
 
It is worth noting that the value of carers to medication management is most clear in cases where 
they are absent. Progression towards a precipice of care is more likely where patients are living 
alone with minimal input from carers in spite of varying levels of capability beyond dementia. The 
study showed several participants with dementia acting as carer to their spouse based on the 
latter’s own health issues. Where both members of an elderly couple are unable to provide 
adequate care for one another, there is a much greater chance of inexorable decline. For 
glaucoma, these cases could easily lie undetected where appointments are often separated by 
six to 12 months. 
Conclusion 
The present study explored the adherence behaviours of those experiencing both glaucoma and 
dementia, and the effect that dementia may have on transitions between states of adherence. 
While the study was limited to patients with mild dementia able to provide their own informed 
consent, the findings offer valuable insights into practical adherence strategies during this phase 
of the condition, as well as for non-dementia patients. These qualitative findings should be 
corroborated in the wider literature given the relatively small sample being investigated. 
Nevertheless, this study’s contribution to the field has shown that dementia is associated with 
shifts in adherence with many active acceptant participants moving to passively adherent or non-
adherent states post-diagnosis.  
 
Numerous factors have been outlined that may slow adherence transitions. The embedding of 
routines, engagement with support organisations and the presence of a carer, alongside 
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attitudinal elements such as believing in the value of medication and taking the progressive 
nature of the condition seriously, appear to have positive mitigating effects. Additionally, a 
positive relationship between patient, carer and healthcare professional was associated with 
better medication management, allowing for person-centred modifications to prescribed regimens 
based on lifestyle patterns and preferences. This negotiated alliance may be most appropriate to 
people with dementia, with the collective care team identifying the optimal method to ensure 
medication is prescribed according to individual needs rather than population-wide guidance 
(Pound et al, 2005; Author, 2013). 10, 40 However, this approach is dependent upon healthcare 
professionals’ knowledge of the dementia diagnosis, something often overlooked in the glaucoma 
clinic. Nevertheless, the value of offering improved education for all glaucoma patients, 
regardless of dementia diagnosis, should be emphasised. The study data demonstrated the 
potential for those with and without dementia to benefit from enhanced learning on the natural 
progression and consequences of glaucoma. 
 
In relation to eye drops, specific issues emerged that arguably contributed to patients becoming 
non-adherent, such as eye drops not easily fitting into aids such as time-based blister packs. The 
use of stickers as visual reminders on such packs, or the provision of preservative-free, single 
dose drops where appropriate, were seen as potential means to integrate eye drops into broader 
medication suites. Other cases showed that the manual dexterity and strength required for eye 
drop instillation was lacking in patients with arthritis. Addressing these issues is predicated on the 
knowledge of their existence, emphasising once more the importance of a carer in their 
identification and the value of clear communication between carers, patients and healthcare 
professionals.   
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Table 1: Sample Characteristics for Patient Cohorts A-C 
Patient Cohort (A) Demographics (N=23) % (n) 
Sex 
   Male 
   Female 
 
43.5 
56.5 
 
10 
13 
Ethnicity 
   White British 
   White Welsh 
   White Scottish 
   Indian 
 
65.2 
17.4 
4.4 
13.0 
 
15 
4 
1 
3 
Age 
   71-80 
   81-90 
   91-100 
 
30.4 
56.5 
13.0 
 
7 
13 
3 
Dementia type 
   Alzheimer’s – Mild to Moderate 
   Mixed Dementia 
   Vascular 
   Not known 
 
65.2 
17.4 
13.0 
4.4 
 
15 
4 
3 
1 
Years since dementia diagnosis 
   1-5 
   6-10 
   11+ 
   Not known 
 
78.2 
8.7 
4.4 
8.7 
 
18 
2 
1 
2 
Glaucoma type 
   Normal tension 
   Primary open angle 
   Ocular hypotension 
 
39.1 
56.5 
4.4 
 
9 
13 
1 
Years since glaucoma diagnosis 
   1-5 
 
26.1 
 
6 
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   6-10 
   11-15 
   16-20 
   21+ 
21.7 
26.1 
17.4 
8.7 
5 
6 
4 
2 
Patient Cohort (B) Demographics (N=6) % (n) 
Sex 
   Male 
   Female 
 
66.7 
33.3 
 
4 
2 
Ethnicity 
   White British 
   White Welsh 
 
83.3 
16.7 
 
5 
1 
Age 
   71-80 
   81-90 
 
66.7 
33.3 
 
4 
2 
Glaucoma type 
   Normal tension 
   Primary open angle 
 
39.1 
56.5 
 
1 
5 
Years since glaucoma diagnosis 
   1-5 
   6-10 
   16-20 
 
50.0 
33.3 
16.7 
 
3 
2 
1 
Patient Cohort (C) Demographics (N=6) 
  
Sex 
   Male 
   Female 
 
50.0 
50.0 
 
3 
3 
Ethnicity 
   White British 
   White Welsh 
 
50.0 
50.0 
 
3 
3 
Age 
   71-80 
   81-90 
 
50.0 
50.0 
 
3 
3 
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Glaucoma type 
   Normal tension 
   Primary open angle 
 
33.3 
66.7 
 
2 
4 
Years since glaucoma diagnosis 
   1-5 
   6-10 
   21+ 
 
50.0 
33.3 
16.7 
 
3 
2 
1 
Secondary condition type 
   Aortic stenosis 
   Chronic back pain 
   Diabetes 
   Diverticulitis 
 
50.0 
16.7 
16.7 
16.7 
 
3 
1 
1 
1 
 
Table 2: Sample Characteristics for Carer Cohort 
Carer Cohort Demographics (N=22) % (n) 
Sex 
   Male 
   Female 
 
18.2 
81.8 
 
4 
18 
Ethnicity 
   White British 
   White Welsh 
   White English 
   Indian 
 
81.8 
4.6 
4.6 
9.0 
 
18 
1 
1 
2 
Age 
   41-50 
   51-60 
   61-70 
   71-80 
   81-90 
   Not known 
 
4.6 
31.8 
4.6 
36.3 
18.2 
4.6 
 
1 
7 
1 
8 
4 
1 
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Table 3: Sample Characteristics for Healthcare Professional Cohort 
Healthcare Professional Cohort Demographics (N=9) % (n) 
Sex 
   Male 
   Female 
 
22.2 
77.8 
 
2 
7 
Ethnicity 
   White British 
   Indian 
 
88.9 
11.1 
 
8 
1 
Age 
   21-30 
   31-40 
   41-50 
   51-60 
 
11.1 
11.1 
22.2 
55.6 
 
1 
1 
2 
5 
Job role 
   Consultant 
   Nurse 
   Optometrist 
   Eye Clinic Liaison Officer 
   Support Worker 
 
22.2 
22.2 
33.3 
11.1 
11.1 
 
2 
2 
3 
1 
1 
 
 
